Developer docs
API playgroundTry for free, no card

Search company profiles

UC Davis Comprehensive Cancer Center

Full company profile

uuid0042tsd

Namestring
UC Davis Comprehensive Cancer Center
Legal namestring
The Regents of the University of California
Company typeenum
Public
Founded yearint
2012
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSacramento, United States
HQ citystring
Sacramento
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology services, cancer treatment, clinical trials, cancer research, pediatric oncology
Industry5 codes
PRIMARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAAAM
Hospital-Integrated Cancer Centers (Acute Oncology Programs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
SECONDARYHLAFABAI
Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAKAFAB
Medical Oncology
SECONDARYHLAKAFAG
Surgical Oncology
NAICS code4 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Offices of Physicians62111
  • Diagnostic Imaging Centers621512
  • Other Outpatient Care Centers62149
SIC code4 codes
  • Services-Hospitals8060
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Health Services8000
Product category
Oncology Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Care and Treatment Services
TypeSubscription Recurring
Description

Revenue generated from providing cancer diagnosis, treatment, and care services to patients through insurance reimbursements, Medicare/Medicaid, and self-pay arrangements

health.ucdavis.edu
2Clinical Research and Trials
TypeLicensing Royalties
Description

Grant funding from NCI, pharmaceutical company-sponsored trials, and government research funding supporting clinical research operations

health.ucdavis.edu
3Professional Services and Referrals
TypeProfessional Services
Description

Specialist consultation services, second opinions, and treatment planning for referred patients from regional healthcare providers

health.ucdavis.edu
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

UC Davis Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing comprehensive cancer care spanning diagnosis, treatment, and survivorship, along with clinical trials, translational research, and education/training programs. It serves the Sacramento region and Northern California through its main Sacramento facility and the affiliated Cancer Care Network, offering specialty programs in radiation oncology, surgical oncology, gynecologic oncology, urologic oncology, hematology/medical oncology, stem cell transplant, hereditary cancer, and pediatric oncology. The center also operates research programs, shared scientific resources, and community outreach initiatives.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

UC Davis Comprehensive Cancer Center is a comprehensive cancer care center offering a unified platform of clinical services, research programs, and patient support. The portfolio includes adult, pediatric, and adolescent/young adult cancer care services; 10 specialty programs (Gynecologic Oncology, Hematology and Medical Oncology, Hereditary Cancer Program, Pediatric Oncology, Radiation Oncology, Sickle Cell Program, Stem Cell Transplant, Surgical Oncology, Urologic Oncology); clinical support services (Laboratory Services, Oncology Pharmacy Services, Medical Interpreting, In-home Care); and patient support services (Support Groups, Patient and Family Learning Center). Research is organized into 4 programs (Biomedical Technology, Cancer Therapeutics, Integrated Cancer Biology, Population Sciences and Cancer Control) supported by 8 shared resources (Biorepository, Biostatistics, Flow Cytometry, Genomics, Immune Modeling/Analysis/Diagnostics, In Vivo Translational Imaging, Molecular Pharmacology and Chemical Biology, Mouse Biology). Community outreach includes the Cancer Care Network, Office of Community Outreach and Engagement, and SCOPE program. Education spans programs for high school students through early career faculty. The center is designated by the National Cancer Institute as one of approximately 59 comprehensive cancer centers in the United States.

Product and service36 records
1Adult Cancer Care
CategoryClinical service
Description

Comprehensive cancer care for adult patients covering diagnosis, treatment, and support services for a wide range of cancer types.

2Pediatric Cancer Care
CategoryClinical service
Description

Specialized cancer treatment and family-centered support services for pediatric patients.

3Adolescents and Young Adults (AYA) Cancer Care
CategoryClinical service
Description

Cancer care services tailored for adolescents and young adults, including fertility preservation, psychosocial support, and educational/career continuity.

4Clinical Trials
CategoryClinical service
Description

Access to new cancer treatments and research studies, with over 200 active trials available for patient enrollment.

5Gynecologic Oncology
CategorySpecialty service
Description

Specialized care for gynecologic cancers including cervical, ovarian, and uterine cancers.

6Hematology and Medical Oncology
CategorySpecialty service
Description

Treatment of blood disorders and cancers using medication-based therapies.

7Hereditary Cancer Program
CategorySpecialty service
Description

Genetic counseling and testing for inherited cancer risk assessment.

8Pediatric Oncology
CategorySpecialty service
Description

Specialized cancer treatment services for children.

9Radiation Oncology
CategorySpecialty service
Description

Cancer treatment using targeted radiation therapy.

10Sickle Cell Program
CategorySpecialty service
Description

Specialized program for sickle cell disease management.

11Stem Cell Transplant
CategorySpecialty service
Description

Bone marrow and stem cell transplantation services for eligible patients.

12Surgical Oncology
CategorySpecialty service
Description

Surgical treatment of cancers.

13Urologic Oncology
CategorySpecialty service
Description

Treatment of cancers affecting the urinary tract and male reproductive organs.

14Laboratory Services
CategoryClinical support service
Description

Diagnostic laboratory testing for cancer diagnosis and monitoring.

15Oncology Pharmacy Services
CategoryClinical support service
Description

Specialized pharmacy services for cancer medications and treatments.

16Medical Interpreting
CategoryClinical support service
Description

Language interpretation services for oncology patients.

17In-home Care and Respite Care
CategoryClinical support service
Description

Care services provided in patient homes and respite support for families.

18Support Groups
CategoryPatient support service
Description

Support groups for cancer patients and their families.

19Patient and Family Learning Center
CategoryPatient support service
Description

Educational resources for patients and families about cancer.

20Biomedical Technology Program
CategoryResearch program
Description

Research program focused on biomedical technology for cancer detection and treatment.

21Cancer Therapeutics Program
CategoryResearch program
Description

Research program developing new cancer treatments and therapies.

22Integrated Cancer Biology Program
CategoryResearch program
Description

Research program studying cancer biology and mechanisms.

23Population Sciences and Cancer Control Program
CategoryResearch program
Description

Research program focused on cancer prevention, control, and population health.

24Biorepository
CategoryShared research resource
Description

Repository for biological samples supporting cancer research.

25Biostatistics
CategoryShared research resource
Description

Statistical support and analysis for cancer research.

26Flow Cytometry
CategoryShared research resource
Description

Cell analysis technology for cancer research.

27Genomics
CategoryShared research resource
Description

Genetic and genomic analysis services for cancer research.

28Immune Modeling, Analysis and Diagnostics
CategoryShared research resource
Description

Immunological analysis and diagnostic services for cancer research.

29In Vivo Translational Imaging
CategoryShared research resource
Description

Live animal imaging for cancer research translation.

30Molecular Pharmacology and Chemical Biology
CategoryShared research resource
Description

Drug development and chemical biology research services.

31Mouse Biology
CategoryShared research resource
Description

Mouse models for cancer research.

32Education and Training Programs
CategoryEducational service
Description

Training programs for high school students, undergraduates, graduate students, postdoctorates, health professionals, and early career faculty in cancer research.

33Cancer Care Network
CategoryCommunity service
Description

Network of affiliated sites extending cancer care to the broader community across Northern California.

34Office of Community Outreach and Engagement
CategoryCommunity service
Description

Community outreach programs and cancer awareness initiatives.

35Cancer Center Office of Population Health
CategoryCommunity service
Description

Population health initiatives for cancer prevention and control.

36Sacramento Citywide Oncology Phase I Program (SCOPE)
CategoryResearch program
Description

Early-phase clinical trial program expanding access to novel cancer therapies in the Sacramento area.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UC Davis Comprehensive Cancer Center is a member of the NCCN, an alliance of the world's leading cancer centers. This membership provides access to evidence-based treatment guidelines, best practices, and collaborative research opportunities across premier cancer institutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

As part of the University of California Health system, UC Davis Comprehensive Cancer Center collaborates with other UC medical centers on research, shares best practices, and participates in system-wide initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integration with UC Davis School of Medicine enables physician training, collaborative research, and access to academic medicine resources.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional healthcare facilities affiliated with the Cancer Care Network that provide local access to cancer care services, extending the center's reach into communities throughout Northern California.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center in Los Angeles; comparable academic cancer center offering multidisciplinary oncology care, clinical trials, and population health research.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center within the University of California system; sister UC institution that competes for research funding, system-wide initiatives, and California oncology patients.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center in Seattle with a strong translational research and bone marrow transplant legacy, comparable to UC Davis's research and stem cell transplant program.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center in Southern California with a strong translational research and Phase I trial focus, comparable to UC Davis's research and clinical trial portfolio.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School; comparable in research intensity, clinical trial portfolio, and academic medicine integration.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at Stanford University, in close geographic proximity to UC Davis; competes for complex oncology cases, clinical trials, and top physician-researcher talent in Northern California.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center integrated within Mayo Clinic; comparable in offering multidisciplinary oncology care, Phase I trials, and population-scale clinical research.

TypeDirect peer
Description

One of the oldest and largest NCI-designated Comprehensive Cancer Centers in the U.S.; benchmarks the gold standard for clinical oncology volume, research output, and brand reputation that UC Davis competes against.

TypeDirect peer
Description

The largest NCI-designated Comprehensive Cancer Center in the U.S., part of the University of Texas system; comparable academic-public governance model and the benchmark for oncology research and clinical excellence.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center in Northern California; competes directly with UC Davis for oncology referrals, clinical trial enrollment, and research funding within the same California catchment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UC Davis Comprehensive Cancer Center

Oncology Servicescancer.ucdavis.edu

UC Davis Comprehensive Cancer Center firmographics

Firmographics
Name
UC Davis Comprehensive Cancer Center
Legal name
The Regents of the University of California
Website
https://cancer.ucdavis.edu
Company type
Public
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

UC Davis Comprehensive Cancer Center industry classification

Industry
Product category
Oncology Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Diagnostic Imaging Centers (621512), Other Outpatient Care Centers (62149)
SIC
Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAAAM
Hospital-Integrated Cancer Centers (Acute Oncology Programs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
SECONDARYHLAFABAI
Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAKAFAB
Medical Oncology
SECONDARYHLAKAFAG
Surgical Oncology

Keywords

  • Oncology services
  • Cancer treatment
  • Clinical trials
  • Cancer research
  • Pediatric oncology

Where UC Davis Comprehensive Cancer Center is headquartered

Location

Headquarters

HQ city
Sacramento
HQ country
United States
HQ region
North America

Offices1 record

Markets served

UC Davis Comprehensive Cancer Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

  1. Clinical Care and Treatment Services: Revenue generated from providing cancer diagnosis, treatment, and care services to patients through insurance reimbursements, Medicare/Medicaid, and self-pay arrangements
  2. Clinical Research and Trials: Grant funding from NCI, pharmaceutical company-sponsored trials, and government research funding supporting clinical research operations
  3. Professional Services and Referrals: Specialist consultation services, second opinions, and treatment planning for referred patients from regional healthcare providers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

UC Davis Comprehensive Cancer Center product offering

Product offering

Core offering

UC Davis Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing comprehensive cancer care spanning diagnosis, treatment, and survivorship, along with clinical trials, translational research, and education/training programs. It serves the Sacramento region and Northern California through its main Sacramento facility and the affiliated Cancer Care Network, offering specialty programs in radiation oncology, surgical oncology, gynecologic oncology, urologic oncology, hematology/medical oncology, stem cell transplant, hereditary cancer, and pediatric oncology. The center also operates research programs, shared scientific resources, and community outreach initiatives.

Product overview

UC Davis Comprehensive Cancer Center is a comprehensive cancer care center offering a unified platform of clinical services, research programs, and patient support. The portfolio includes adult, pediatric, and adolescent/young adult cancer care services; 10 specialty programs (Gynecologic Oncology, Hematology and Medical Oncology, Hereditary Cancer Program, Pediatric Oncology, Radiation Oncology, Sickle Cell Program, Stem Cell Transplant, Surgical Oncology, Urologic Oncology); clinical support services (Laboratory Services, Oncology Pharmacy Services, Medical Interpreting, In-home Care); and patient support services (Support Groups, Patient and Family Learning Center). Research is organized into 4 programs (Biomedical Technology, Cancer Therapeutics, Integrated Cancer Biology, Population Sciences and Cancer Control) supported by 8 shared resources (Biorepository, Biostatistics, Flow Cytometry, Genomics, Immune Modeling/Analysis/Diagnostics, In Vivo Translational Imaging, Molecular Pharmacology and Chemical Biology, Mouse Biology). Community outreach includes the Cancer Care Network, Office of Community Outreach and Engagement, and SCOPE program. Education spans programs for high school students through early career faculty. The center is designated by the National Cancer Institute as one of approximately 59 comprehensive cancer centers in the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Adult Cancer Care Comprehensive cancer care for adult patients covering diagnosis, treatment, and support services for a wide range of cancer types.
  • Pediatric Cancer Care Specialized cancer treatment and family-centered support services for pediatric patients.
  • Adolescents and Young Adults (AYA) Cancer Care Cancer care services tailored for adolescents and young adults, including fertility preservation, psychosocial support, and educational/career continuity.
  • Clinical Trials Access to new cancer treatments and research studies, with over 200 active trials available for patient enrollment.
  • Gynecologic Oncology Specialized care for gynecologic cancers including cervical, ovarian, and uterine cancers.
  • Hematology and Medical Oncology Treatment of blood disorders and cancers using medication-based therapies.
  • Hereditary Cancer Program Genetic counseling and testing for inherited cancer risk assessment.
  • Pediatric Oncology Specialized cancer treatment services for children.
  • Radiation Oncology Cancer treatment using targeted radiation therapy.
  • Sickle Cell Program Specialized program for sickle cell disease management.
  • Stem Cell Transplant Bone marrow and stem cell transplantation services for eligible patients.
  • Surgical Oncology Surgical treatment of cancers.
  • Urologic Oncology Treatment of cancers affecting the urinary tract and male reproductive organs.
  • Laboratory Services Diagnostic laboratory testing for cancer diagnosis and monitoring.
  • Oncology Pharmacy Services Specialized pharmacy services for cancer medications and treatments.
  • Medical Interpreting Language interpretation services for oncology patients.
  • In-home Care and Respite Care Care services provided in patient homes and respite support for families.
  • Support Groups Support groups for cancer patients and their families.
  • Patient and Family Learning Center Educational resources for patients and families about cancer.
  • Biomedical Technology Program Research program focused on biomedical technology for cancer detection and treatment.
  • Cancer Therapeutics Program Research program developing new cancer treatments and therapies.
  • Integrated Cancer Biology Program Research program studying cancer biology and mechanisms.
  • Population Sciences and Cancer Control Program Research program focused on cancer prevention, control, and population health.
  • Biorepository Repository for biological samples supporting cancer research.
  • Biostatistics Statistical support and analysis for cancer research.
  • Flow Cytometry Cell analysis technology for cancer research.
  • Genomics Genetic and genomic analysis services for cancer research.
  • Immune Modeling, Analysis and Diagnostics Immunological analysis and diagnostic services for cancer research.
  • In Vivo Translational Imaging Live animal imaging for cancer research translation.
  • Molecular Pharmacology and Chemical Biology Drug development and chemical biology research services.
  • Mouse Biology Mouse models for cancer research.
  • Education and Training Programs Training programs for high school students, undergraduates, graduate students, postdoctorates, health professionals, and early career faculty in cancer research.
  • Cancer Care Network Network of affiliated sites extending cancer care to the broader community across Northern California.
  • Office of Community Outreach and Engagement Community outreach programs and cancer awareness initiatives.
  • Cancer Center Office of Population Health Population health initiatives for cancer prevention and control.
  • Sacramento Citywide Oncology Phase I Program (SCOPE) Early-phase clinical trial program expanding access to novel cancer therapies in the Sacramento area.

Companies that use UC Davis Comprehensive Cancer Center

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

UC Davis Comprehensive Cancer Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

UC Davis Comprehensive Cancer Center partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • National Comprehensive Cancer Network (NCCN)coreStrategic or Co-development PartnerUC Davis Comprehensive Cancer Center is a member of the NCCN, an alliance of the world's leading cancer centers. This membership provides access to evidence-based treatment guidelines, best practices, and collaborative research opportunities across premier cancer institutions.
  • University of California Health SystemcoreStrategic or Co-development PartnerAs part of the University of California Health system, UC Davis Comprehensive Cancer Center collaborates with other UC medical centers on research, shares best practices, and participates in system-wide initiatives.
  • UC Davis School of MedicinecoreStrategic or Co-development PartnerIntegration with UC Davis School of Medicine enables physician training, collaborative research, and access to academic medicine resources.
  • Cancer Care Network AffiliatescoreChannel Partner/ Reseller/ DistributorRegional healthcare facilities affiliated with the Cancer Care Network that provide local access to cancer care services, extending the center's reach into communities throughout Northern California.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

UC Davis Comprehensive Cancer Center competitors and assessment

Company assessment

Direct peers

  • USC Norris Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Los Angeles; comparable academic cancer center offering multidisciplinary oncology care, clinical trials, and population health research.
  • UCLA Jonsson Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center within the University of California system; sister UC institution that competes for research funding, system-wide initiatives, and California oncology patients.
  • Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center in Seattle with a strong translational research and bone marrow transplant legacy, comparable to UC Davis's research and stem cell transplant program.
  • City of Hope Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Southern California with a strong translational research and Phase I trial focus, comparable to UC Davis's research and clinical trial portfolio.
  • Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School; comparable in research intensity, clinical trial portfolio, and academic medicine integration.
  • Stanford Cancer Institute: NCI-designated Comprehensive Cancer Center at Stanford University, in close geographic proximity to UC Davis; competes for complex oncology cases, clinical trials, and top physician-researcher talent in Northern California.
  • Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center integrated within Mayo Clinic; comparable in offering multidisciplinary oncology care, Phase I trials, and population-scale clinical research.
  • Memorial Sloan Kettering Cancer Center: One of the oldest and largest NCI-designated Comprehensive Cancer Centers in the U.S.; benchmarks the gold standard for clinical oncology volume, research output, and brand reputation that UC Davis competes against.
  • MD Anderson Cancer Center: The largest NCI-designated Comprehensive Cancer Center in the U.S., part of the University of Texas system; comparable academic-public governance model and the benchmark for oncology research and clinical excellence.
  • UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Northern California; competes directly with UC Davis for oncology referrals, clinical trial enrollment, and research funding within the same California catchment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

UC Davis Comprehensive Cancer Center social profiles

Digital presence

UC Davis Comprehensive Cancer Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UC Davis Comprehensive Cancer Center leadership team

Management profile

Number of profiles

Profiles1 record

UC Davis Comprehensive Cancer Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UC Davis Comprehensive Cancer Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UC Davis Comprehensive Cancer Center

What does UC Davis Comprehensive Cancer Center do?

UC Davis Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing comprehensive cancer care spanning diagnosis, treatment, and survivorship, along with clinical trials, translational research, and education/training programs. It serves the Sacramento region and Northern California through its main Sacramento facility and the affiliated Cancer Care Network, offering specialty programs in radiation oncology, surgical oncology, gynecologic oncology, urologic oncology, hematology/medical oncology, stem cell transplant, hereditary cancer, and pediatric oncology. The center also operates research programs, shared scientific resources, and community outreach initiatives.

Is UC Davis Comprehensive Cancer Center a public or private company?

UC Davis Comprehensive Cancer Center is a public company. It is classified as state government owned and is currently operating.

When was UC Davis Comprehensive Cancer Center founded?

UC Davis Comprehensive Cancer Center was founded in 2012. It employs 51 to 100 people.

Where is UC Davis Comprehensive Cancer Center based?

UC Davis Comprehensive Cancer Center is headquartered in Sacramento, United States, in the North America region.

How does UC Davis Comprehensive Cancer Center make money?

Three revenue lines are on record. Clinical Care and Treatment Services are the primary driver. The others are clinical Research and Trials and professional Services and Referrals.

Who are UC Davis Comprehensive Cancer Center's main competitors?

Direct peers on record are USC Norris Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, Fred Hutchinson Cancer Center, City of Hope Comprehensive Cancer Center, Dana-Farber Cancer Institute, Stanford Cancer Institute, Mayo Clinic Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center and UCSF Helen Diller Family Comprehensive Cancer Center.

Does UC Davis Comprehensive Cancer Center have an API?

No public API is recorded for UC Davis Comprehensive Cancer Center.

What industry is UC Davis Comprehensive Cancer Center in?

UC Davis Comprehensive Cancer Center's product category is Oncology Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNorCal Auto Group Deepens Support for Hyundai Hope on Wheels with $100,000 for UC Davis Comprehensive Cancer CenterNorCal Auto Group contributed $50,000 to UC Davis Comprehensive Cancer Center, matched by Hyundai Hope on Wheels to $100,000. The group also attended a check presentation at UCSF Benioff Children's Hospital and a handprint ceremony at UC Davis. Hyundai Hope on Wheels has directed over $300 million to pediatric cancer research since 1998.American City Business JournalsUC Davis cancer center wins nearly $18M federal grantUC Davis Comprehensive Cancer Center has retained the federal government's highest designation for cancer centers and secured nearly $18 million to support its research and clinical operations over the next five years. The award amount and the specific federal program were not disclosed in the report.Mirage NewsCancer Center Earns Renewed 'comprehensive' DesignationThe National Cancer Institute has renewed the comprehensive designation of UC Davis Comprehensive Cancer Center, accompanied by an $18 million grant over five years. This recognition places the center among only 58 elite institutions nationwide and validates its excellence in research, clinical care, and prevention efforts.UC Davis College of Biological SciencesUC Davis Comprehensive Cancer CenterUC Davis Comprehensive Cancer Center is recruiting participants for the ASPIRE study, a National Cancer Institute-funded longitudinal cohort of Asian Americans. The study aims to recruit 20,000 participants across six sites to address rising cancer rates in this population. It plans to deliver insights to reshape national cancer prevention strategies.GlobeNewswireIO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer CenterIO Biotech announced the first patient was dosed in an investigator-initiated trial at UC Davis Comprehensive Cancer Center evaluating its vaccine IO102-IO103 with pembrolizumab in non-muscle invasive bladder cancer. The trial is one of five supporting IO102-IO103 across cancer types, with a Phase 3 trial ongoing in melanoma.UC Davis College of Biological SciencesNational recognition elevates UC Davis Health for its premier lung cancer careUC Davis Comprehensive Cancer Center has been designated as a GO2 for Lung Cancer Center of Excellence, recognizing its adherence to evidence-based screening guidelines and coordinated patient care. The designation highlights the center's implementation of low-dose CT screening protocols and multidisciplinary follow-up processes to improve early detection and survival rates.PR NewswireNCCN Announces UC Davis Comprehensive Cancer Center as 31st Member InstitutionThe National Comprehensive Cancer Network (NCCN) announced that its Board of Directors elected UC Davis Comprehensive Cancer Center as its 31st Member Institution, joining a not-for-profit alliance of leading academic cancer centers in the United States. UC Davis is the only National Cancer Institute-designated center serving Central Valley and inland Northern California, a region of over 6 million people, providing care to more than 15,000 adults and children annually. As a member, UC Davis will now appoint experts to participate in over 60 panels responsible for more than 80 NCCN Clinical Practice Guidelines covering most cancer types.GlobeNewswireTempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer PatientsTempus and UC Davis Comprehensive Cancer Center announced a precision medicine partnership to use Next Generation Sequencing for hematological malignancies and pancreatic cancer. Tempus will perform molecular sequencing and analysis for a group of patients, using machine learning to guide treatment for those unlikely to respond to conventional therapies.